Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Jul 15, 2019 · 10-Q · 45 days after period end · 0001640334-19-001361
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$344.88K | -$577.86K | -$96.63K | -$5.05K |
| EPS Diluted | -$0.40 | -$0.36 | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended May 31, 2019 · filed Jul 15, 2019 · 45 d after period end
